Tag Archive: Tamoxifen

New research identifies breast cancer patients likely to respond to tamoxifen

by

Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.… Continue reading

Cancer Lessons from 9-11: Building Up Support From the Ground Floor

by

Some of you may recognise Jan Hasak, from her recent insightful comments on the JBBC blog, so I am delighted to have an opportunity to learn more about her and to feature her as today’s guest… Continue reading

Don’t cut short Tamoxifen

by

Up to half of women stop taking the drug prematurely but in doing so significantly reduce their survival odds, says Cancer Research UK. Data shows for every hundred women who complete the full… Continue reading

Updates from San Antonio Breast Cancer Conference

by

I look forward each year to hearing about the latest studies to emerge from the annual San Antonio Breast Cancer Conference – an international scientific symposium for interaction and exchange among basic scientists… Continue reading

Friday Round-Up

by

Time for this week’s round-up of the best of the blog posts which I’ve read over the past week. These are the posts that have moved me, taught me something, inspired me, and which… Continue reading

Latest research on treatment of DCIS

by

Women with the most common type of non-invasive breast cancer known as ductal carcinoma in situ (DCIS) are significantly less likely to develop invasive disease if they are given radiotherapy after surgery, and the effect… Continue reading

Cough medicine may help identify how tamoxifen is metabolised

by

Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research. The findings suggest that it could… Continue reading

Boosting Tamoxifen’s Effectiveness

by

SCIENTISTS in London have found a potential new way of boosting the effectiveness of the anti-breast cancer drug, tamoxifen. The work carried out by and her team at the Breakthrough Breast Cancer Research… Continue reading

Hormonal treatment and fertility

by

If your cancer is oestrogen sensitive (ER+), you will most likely be advised to undergo some form of hormonal treatment after your chemotherapy and radiotherapy has finished. This is usually in the form of… Continue reading

At risk women not having mammograms

by

Women who have been treated for ductal carcinoma in situ (DCIS) tend to stop following the recommended guidelines for mammography screening over time, despite the fact that they still have a higher-than-average risk… Continue reading